Real-World Outcomes of Patients with Relapsed/Refractory Multiple Myeloma Treated with Teclistamab and Talquetamab; A Multicenter Analysis from the Greek Myeloma Study Group

被引：0

作者：

Ntanasis-Stathopoulos, Ioannis ^{[1
]}

Katodrytou, Eirini ^{[2
]}

Hatjiharissi, Evdoxia ^{[3
]}

Spanoudakis, Emmanouil ^{[4
]}

Douka, Vasiliki ^{[5
,6
]}

Fotiou, Despina ^{[1
]}

Labropoulou, Vasiliki ^{[7
]}

Dalampira, Dimitra ^{[2
]}

Spiliopoulou, Vasiliki ^{[1
]}

Papadopoulou, Theodosia ^{[2
]}

Christoulas, Dimitrios ^{[8
]}

Malandrakis, Panagiotis ^{[1
]}

Bouchla, Anthi ^{[9
]}

Pappa, Vasiliki ^{[10
]}

Kastritis, Efstathios ^{[1
]}

Terpos, Evangelos ^{[1
]}

Dimopoulos, Meletios ^{[1
]}

Gavriatopoulou, Maria ^{[1
]}

机构：

[1] Natl & Kapodistrian Univ Athens, Sch Med, Dept Clin Therapeut, Athens, Greece

[2] Theagenio Canc Hosp, Dept Hematol, Thessaloniki, Greece

[3] Aristotle Univ Thessaloniki, AHEPA Univ Hosp, Sch Med, Dept Internal Med 1,Div Hematol, Thessaloniki, Greece

[4] Univ Hosp Alexandroupolis, Dept Hematol, Alexandroupolis, Greece

[5] Papanikolaou Gen Hosp, Dept Hematol, Thessaloniki, Greece

[6] Papanikolaou Gen Hosp, Bone Marrow Transplantat Unit, Thessaloniki, Greece

[7] Univ Patras, Med Sch, Div Hematol, Patras, Greece

[8] 251 Gen AirForce Hosp, Dept Haematol, Athens, Greece

[9] Natl & Kapodistrian Univ Athens, Attikon Univ Hosp, Dept Internal Med 2, Hematol Div, Haidari, Greece

[10] Attikon Gen Hosp, Dept Hematol, Athens, Greece

来源：

BLOOD | 2024年 / 144卷

关键词：

D O I：

10.1182/blood-2024-206900

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：6988 / 6990

页数：3

共 50 条

[1] A German Multicenter Real-World Analysis of Talquetamab in 102 Patients With Relapsed/ Refractory Multiple Myeloma
Frenking, Jan
Riedhammer, Christine
Besemer, Britta
Braune, Jan
Brioli, Annamaria
Brunner, Franziska
Dampmann, Maria
Gezer, Deniz
Goldman-Mazur, Sarah
Haenel, Mathias
Hanoun, Christine
Hoegner, Marion
Kolditz, Katja
Kos, Igor
Kull, Miriam
Leitner, Theo
Merz, Maximilan
von Metzler, Ivana
Michel, Christian S.
Teipel, Raphael
Theurich, Sebastian
Waesch, Ralph
Zukovs, Romans
Rasche, Leo
Raab, Marc-Steffen
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S52 - S53
[2] Talquetamab plus Teclistamab in Relapsed or Refractory Multiple Myeloma
Cohen, Yael C.
Magen, Hila
Gatt, Moshe
Sebag, Michael
Kim, Kihyun
Min, Chang-Ki
Ocio, Enrique M.
Yoon, Sung-Soo
Chu, Michael P.
Rodriguez-Otero, Paula
Avivi, Irit
Quijano Carde, Natalia A.
Kumar, Ashwini
Krevvata, Maria
Peterson, Michelle R.
Di Scala, Lilla
Scott, Emma
Hilder, Brandi
Vanak, Jill
Banerjee, Arnob
Oriol, Albert
Morillo, Daniel
Mateos, Maria-Victoria
NEW ENGLAND JOURNAL OF MEDICINE, 2025, 392 (02): : 138 - 149
[3] Real-World Clinical Outcomes of Teclistamab and Talquetamab in Relapsed/Refractory Multiple Myeloma (RRMM): A UK Single-Centre Experience
Feixas, Pablo Tenorio
Cox, Catrin
Peer, Xavier
Cuthill, Kirsty
Benjamin, Reuben
Gunawan, Arief
Cuadrado, Maria
de Farias, Madson Correia
Jones, John
Shin, Jin-Sup
Batool, Asma
Bowcock, Stella
Omer, Musab
Tawde, Prachi
Bailey, Katharine
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S92 - S92
[4] Real-world evaluation of teclistamab for the treatment of relapsed/refractory multiple myeloma (RRMM): an International Myeloma Working Group Study
Tan, Carlyn Rose
Asoori, Sireesha
Huang, Chiung-Yu
Brunaldi, Larissa
Popat, Rakesh
Kastritis, Efstathios
Martinez-Lopez, Joaquin
Bansal, Radhika
Corraes, Andre De Menezes Silva
Chhabra, Saurabh
Parrondo, Ricardo
Ailawadhi, Sikander
Fotiou, Despina
Dimopoulos, Meletios A.
Yong, Kwee
Mactier, Catriona
Lau, Chris
Corona, Magdalena
Marin, Adolfo Jesus Saez
Mian, Hira
Durie, Brian GM.
Usmani, Saad Z.
Martin, Thomas G.
Lin, Yi
BLOOD CANCER JOURNAL, 2025, 15 (01):
[5] Real-World Experience with Teclistamab for Relapsed/ Refractory Multiple Myeloma from the US Myeloma Immunotherapy Consortium
Razzo, Beatrice
Grajales-Cruz, Ariel
Atrash, Shebli
Ferreri, Christopher
Goyal, Anmol
Pasvolsky, Oren
Banerjee, Rahul
Julian, Kelley
Forsberg, Peter
Herr, Megan
Lin, Yi
Susanibar-Adaniya, Sandra
Khouri, Jack
Vazquez-Martinez, Mariola
Lee, Hans
Portuguese, Andrew
Sborov, Douglas W.
Dima, Danai
Davis, James
Kaur, Gurbakhash
Shune, Leyla
Hansen, Doris
Sidana, Surbhi
Garfall, Alfred
Richard, Shambavi
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S82 - S83
[6] Safety and Efficacy of Teclistamab in Patients with Relapsed/ Refractory Multiple Myeloma: A Real-World Experience
Dima, Danai
Davis, James A.
Ahmed, Nausheen
Jia, Xuefei
Sannareddy, Aishwarya
Shaikh, Hira
Shune, Leyla
Kaur, Gurbakhash
Khouri, Jack
Afrough, Aimaz
Strouse, Christopher
Lochner, Jonathan
Mahmoudjafari, Zahra
Raza, Shahzad
Valent, Jason
Anderson Jr, Larry D.
Anwer, Faiz
Abdallah, Al-Ola
Hashmi, Hamza
TRANSPLANTATION AND CELLULAR THERAPY, 2024, 30 (03): : 308.e1 - 308.e13
[7] Teclistamab in relapsed refractory multiple myeloma: multi-institutional real-world study
Meera Mohan
Jorge Monge
Nishi Shah
Danny Luan
Mark Forsberg
Vineel Bhatlapenumarthi
Metodi Balev
Anannya Patwari
Heloise Cheruvalath
Divaya Bhutani
Sharmilan Thanendrarajan
Binod Dhakal
Maurizio Zangari
Samer Al-Hadidi
Dennis Cooper
Suzanne Lentzsch
Frits van Rhee
Anita D’Souza
Aniko Szabo
Carolina Schinke
Rajshekhar Chakraborty
Blood Cancer Journal, 14
[8] Teclistamab in Relapsed Refractory Multiple Myeloma: Multi-Institutional Real-World Study
Mohan, Meera
Shah, Nishi
Luan, Danny
Monge, Jorge
Forsberg, Mark
Bhatlapenumarthi, Vineel
Balev, Metodi
Patwari, Anannya
Cheruvalath, Heloise
Bhutani, Divaya
Thanendrarajan, Sharmilan
Dhakal, Binod
Zangari, Maurizio
Al Hadidi, Samer
Cooper, Dennis L.
Lentzsch, Suzanne
van Rhee, Frits
D'Souza, Anita
Szabo, Aniko
Schinke, Carolina
Chakraborty, Rajshekhar
BLOOD, 2023, 142
[9] Teclistamab in relapsed refractory multiple myeloma: multi-institutional real-world study
Mohan, Meera
Monge, Jorge
Shah, Nishi
Luan, Danny
Forsberg, Mark
Bhatlapenumarthi, Vineel
Balev, Metodi
Patwari, Anannya
Cheruvalath, Heloise
Bhutani, Divaya
Thanendrarajan, Sharmilan
Dhakal, Binod
Zangari, Maurizio
Al-Hadidi, Samer
Cooper, Dennis
Lentzsch, Suzanne
van Rhee, Frits
D'Souza, Anita
Szabo, Aniko
Schinke, Carolina
Chakraborty, Rajshekhar
BLOOD CANCER JOURNAL, 2024, 14 (01)
[10] Teclistamab in Relapsed/Refractory Multiple Myeloma: Real-World Outcomes at a Single Academic Center in the Midwest
Stepanovic, Adam
Abonour, Rafat
Abu Zaid, Mohammad
Farag, Sherif
Lee, Kelvin P.
Suvannasankha, Attaya
BLOOD, 2023, 142

← 1 2 3 4 5 →